About David Cohne
David Cohne has 20 years of experience as an investment analyst and writer. Prior to StockNews, David spent eleven years as a consultant providing outsourced investment research and content to financial services companies, hedge funds, and online publications. He also served as a Consultant and Senior Investment Writer to NextShares Solutions LLC where he provided content on Exchange-Traded Products.
Previously, David was Vice President and Director of Research at The Rankings Service, an independent investment research and consulting firm that scored and ranked mutual fund managers. He also served as Vice President and Senior Analyst at Fundworks Inc, a financial newsletter publishing firm. David started his career in portfolio management at Adviser Investments, an independent wealth management firm. He received an undergraduate degree in Economics at Brandeis University and an MBA from Arizona State University.
David enjoys researching and writing about stocks and the markets. He takes a fundamental quantitative approach in evaluating stocks for readers.
Recent Articles By David Cohne
Penske Automotive Group: My Value Stock of the Week
Penske Automotive Group, Inc. (PAG) recently reported a stellar quarter where both earnings and revenues beat expectations and rose year over year. The company is benefiting from strong demand for its truck leasing services. The stock is also extremely undervalued which makes it one you don't want to miss.
How Will GDP Slowdown Impact the Stock Market in Q4?
Last Friday, it was reported that GDP growth slowed considerably. But the good news was that it didn't grind to a halt. But if economic growth is slowing, is that a concern for the S&P 500 (SPY) as less productivity could lead to lower profit margins? The answer is no, and I will tell you why and more below in this week's market commentary....
Here's My Top Value Stock to Buy Right Now
With stocks hitting new highs again today, it's always nice to find a stock that isn't overvalued. Exelixis, Inc. (EXEL) is one such stock. The company's lead molecule, cabozantinib, offers treatment for numerous indications, which makes this an intriguing pick. Investors looking for value stocks should take notice.
3 Inflation-Resistant Stocks to Buy for November
As the global economy continues to recover from the COVID-19 pandemic, one area of concern is certainly inflation. Pent-up demand from consumers and supply chain constraints have led to a rise in prices for many products. This inflation may continue for another year, so investors should consider looking into inflation-resistant stocks such as EOG Resources, Inc. (EOG), Olin Corporation (OLN), and Coca-Cola Company (KO).
3 Stocks Poised for Jaw-Dropping Growth
Already a week into earnings season, corporate profits look strong again. But, we can't expect this growth to last for so many stocks as we continue to move past the lows of the pandemic. That's why investors need to consider stocks with very strong growth potential in the years to come. Sanderson Farms, Inc. (SAFM), Ulta Beauty, Inc. (ULTA), and SBA Communications Corporation (SBAC) are three such stocks.
How Supply Chain Challenges and Inflation Will Impact the Stock Market
One of the central themes of the past few months has been inflation. It is also a significant theme as earnings reports continue to file in. One of the biggest questions ahead of earnings season was how supply chain challenges and inflation would affect corporate margins. The answer is, so far, so good. But should we be concerned with inflation and its effect on the S&P 500 (SPY) going forward? I’ll discuss this and more below…
3 Buy-Rated Stocks in A-Rated Industries
Our POWR Ratings system makes it easy to find stocks that are more likely to outperform. Investors just need to look for stocks that have an overall grade of A or B. But, you can go a step further, and only invest in A or B stocks in industries rated an A or B. That's why investors should consider Gartner, Inc. (IT), Signet Jewelers (SIG), and CRA International, Inc. (CRAI), which are three such stocks.
GlaxoSmithKline: My Top Value Stock for the Week
GlaxoSmithKline PLC (GSK) is one of the biggest pharmaceuticals companies in the world. The firm, which has a focus in HIV, vaccines, and cancers, is seeing a lot of success with new drugs and plenty more in the pipeline. Better yet, the stock is still very undervalued, which is why investors should consider adding it to their portfolios.
Buy These 3 Tech Stocks Before They Soar Further
Tech stocks, which were underperformers at the start of the year, have made their way back as investors have been buying on the dip. Many of these stocks, which include Applied Materials Inc. (AMAT), KLA Corporation (KLAC), and Amdocs Limited (DOX) are currently in an uptrend and are expected to continue this momentum.